Inventaire - els teus amics i comunitats són la teva millor biblioteca

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

publicat a: Journal of the National Cancer Institute

date of publication: 2017-07-01

idioma: anglès

tema principal: xenograft

Cites articles 22

Date

Títol

Autors

2016-07-05

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer

Elisabetta Marangoni, Ian J Majewski, Manel Esteller i Badosa, Edwin Cuppen, Frans Hogervorst, Esther H Lips
2015-12-18

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

Charles M. Perou, Aleix Prat, Aranzazu Fernandez-Martinez, Katherine A Hoadley, Ana Arance, Maggie Chon U Cheang
2015-10-19

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

John Monahan, Derek Y Chiang, Marion Wiesmann
2015-08-22

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Steven N. Hart, Krishna R Kalari, Kevin J Thompson, Xiaojia Tang, Vera J Suman, James N Ingle, Judy Boughey, Matthew P Goetz, Jason P Sinnwell, Richard Weinshilboum, Eric D Wieben, Liewei Wang, Donald W Northfelt, Poulami Barman, Ann M Moyer, Alvaro Moreno-Aspitia, Amy L Conners, Travis J Dockter, Hugues Sicotte, Jeanette E Eckel-Passow, Marissa S Ellingson, Michelle McDonough
2015-02-10

Patient-derived xenograft models of breast cancer and their predictive power

Geoffrey J. Lindeman, Jane Visvader
2015-04

Prioritizing therapeutic targets using patient-derived xenograft models
2014-01-01

edgeR for differential RNA-seq and ChIP-seq analysis: an application to stem cell biology

Mark D. Robinson
2014-02-14

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Sandra M. Swain, Charles M. Perou, Gunter Minckwitz, Wolfgang Eiermann, Pinuccia Valagussa, Sibylle Loibl, Holger Eidtmann, Michael Untch, Josep Baselga i Torres, Luca Gianni, Vladimir Semiglazov, Soonmyung Paik, Peter A. Fasching, Eleftherios P Mamounas
2013-09-26

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts

Elaine Mardis, Sherri R Davies, Aleix Prat, Obi Griffith, Charles M. Perou, Ana Maria Gonzalez-Angulo, Joshua F. McMichael, Richard K. Wilson, Gordon B. Mills, Shunqiang Li, Katherine DeSchryver
2013-08-15

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

Funda Meric-Bernstam, Jennifer A. Pietenpol, Brian D. Lehmann, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
2013-07-11

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Eric Lander, Carrie Sougnez, Gad Getz, Kristian Cibulskis, Wendy Winckler, Daniel Auclair, Lauren Ambrogio, Gordon Saksena, Eran Hodis, Nicolas Stransky, Douglas Voet, Kristin Ardlie, Elizabeth Nickerson, Marcin Imielinski, Aaron McKenna, Melissa Parkin, Adam Kiezun, Petar Stojanov, Yotam Drier, Alfredo Hidalgo-Miranda, Trevor J Pugh, Matthew Meyerson, Jaume Mora, Dmitry A. Gordenin, Kimberly Stegmaier, Craig H Mermel, Stacey Gabriel, Levi A Garraway, Todd Golub, Andrey Sivachenko, Charles W Roberts, Jens G. Lohr, Chip Stewart, Alex H Ramos
2013-06-27

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

Thomas Karn, Carsten Denkert, Peter A. Fasching, Sibylle Loibl
2012-10-04

Comprehensive molecular portraits of human breast tumours

Hai Hu
2012-09-02

Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors

Laura Esserman, Max S Wicha, Joe W Gray, Paul Spellman
2012-06-29

Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
2012-06-10

Whole-genome analysis informs breast cancer response to aromatase inhibition

Elaine Mardis, Reece J Goiffon, Cyriac Kandoth, William Schierding, Kelly K Hunt, Laura Esserman, Joshua F. McMichael, Vera J Suman, Richard K. Wilson, Lucinda Fulton, Michael D McLellan, Dan Koboldt, Timothy Ley, Joshua M Stuart, Jacqueline E Snider, David Dooling, Tammi L Vickery, Jeremy Hoog, Ryan Demeter, Christopher A Maher, Katherine DeSchryver
2012-04-18

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Anne-Lise Børresen-Dale, Anita Langerød, Florian Markowetz, Carlos Caldas, Sarah E. Pinder, Ian Ellis, Christina Curtis, Suet-feung Chin, Alison Dunning
2012-04-04

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Gavin Ha, Damian Yap, Daniel Lai, Inanc Birol, Malachi Griffith, Gregg B Morin, Suet-feung Chin, Christina Curtis, John R. Mackey, Wyeth Wasserman, Steven Jones, Connie Eaves, Jiarui Ding, Samuel Aparicio, Oscar M Rueda, Sohrab P Shah, Paul D P Pharoah, Angela Burleigh, Yongjun Zhao, David Huntsman, Stephen K L Chia, Karey Shumansky, Gulisa Turashvili
2011-06-27

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2007-10

The NCBI dbGaP database of genotypes and phenotypes

James Ostell, Eugene Yaschenko, Karl Sirotkin, Michael Feolo, Jeffrey Beck, Kimberly A. Tryka, Stephen T Sherry
2007-09-04

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy

Christos Hatzis, Gabriel N Hortobagyi, Bryan T. Hennessy, S. Eva Singletary, Aman U Buzdar
1991-11

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Ian Ellis

Article - wd:Q33614238

Welcome to Inventaire

la biblioteca dels teus amics i comunitats

saber més